Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-28

Clinical Trial Update: Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether parecoxib provides morphine-sparing analgesia after radical prostatectomy; the study was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Parecoxib (parecoxib)

Snippet

Sponsor: Pfizer | Conditions: Pain, Postoperative | Phase 4 | Status: TERMINATED | Results posted: 2011-10-28